Use of beta-adrenergic inverse agonists for smoking cessation

• 收藏
• 分享

专利权人:

Inverseon; Inc.

发明人:

Bond, Richard A.,Glass, Mitchell

申请号：

AU2012205791

公开号：

AU2012205791A1

申请日:

2012.01.09

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

The chronic use of p-adrenergic inverse agonists such as nadolol, carvedilol, and ICI-118,551 provides an improved method for the treatment of mucus hypersecretion in subjects with such mucus hypersecretion. One aspect of a method according to the present invention is a method of preventing or controlling mucus hypersecretion in the respiratory tract comprising administering a therapeutically effective quantity of a p-adrenergic inverse agonist to a subject with mucus hypersecretion or at risk of mucus hypersecretion. The invention further encompasses pharmaceutical compositions comprising the p-adrenergic inverse agonist and the additional compound.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/